<p>Vicarious Surgical Inc. has amended its executive compensation agreements for its Chief Executive Officer, Stephen From, and Chief Financial Officer, Sarah Romano. Under the new terms, if Mr. From is terminated without cause or resigns for good reason, he will receive a severance payment equal to one year of his base salary, a pro-rata portion of his target bonus, and COBRA premiums for 12 months. If such termination occurs within three months before or 12 months after a change in control, his severance increases to two times his annual base salary plus pro-rata target bonus and COBRA premiums for 24 months, with full vesting of outstanding time-based equity awards. For Ms. Romano, the agreement provides for severance equal to six months of base salary, a pro-rata portion of her target bonus, and COBRA premiums for six months if terminated without cause or resigning for good reason. In a change in control scenario, she would receive two times her six-month base salary, pro-rata target bonus, COBRA premiums for 12 months, and full vesting of time-based equity awards. All severance is contingent on the execution and non-revocation of a separation agreement with customary terms. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vicarious Surgical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-010807), on February 02, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here</p>

RBOT

SBIO

Reuters

Vicarious Surgical

VanEck Biotech ETF

iShares US Medical Devices

First Trust NYSE Arca Biotech Index Fd

SPDR S&P Health Equip

Proshares Ultra Nasdaq Biotech

ALPS Medical Breakthrough

Invesco Biotechnology & Genome ETF

SPDR S&P Biotech

iShares Biotechnology ETF

Vicarious Surgical Updates Executive Severance and Change-in-Control Compensation